Richard A. Heyman's Trading History
| ORICOric Pharmaceuticals | Jul 28, 2026 | Director | Uninformative Buy | 5.60K | $2.26M | |
| ELVNEnliven Therapeutics | Feb 19, 2026 | Director | Uninformative Sell | 32.19K | $7.61M | |
| RYZBRayzeBio, Inc. | Feb 27, 2024 | ― | Uninformative Sell | 22.97M | $0.00 | |
| PMVPPMV Pharmaceuticals | Jun 02, 2021 | Director | Uninformative Buy | 959.25K | $0.00 | |
| KANTKineta | Feb 03, 2021 | ― | Uninformative Buy | ― | $2.73K | |
| RCPTReceptos | Aug 27, 2015 | ― | Uninformative Sell | ― | $0.00 | |
| VIVSVivoSim Labs | ― | Director | ― | $0.00 | ||
| MTCRMetacrine | ― | ― | ― | ― | ||
| GRTSQGritstone bio | ― | ― | ― | ― |
You May Also Like
Richard A. Heyman insider profile FAQ
What stocks does Richard A. Heyman hold?
Richard A. Heyman holds: ORIC, RCPT, KANT, GRTSQ, ELVN, MTCR, PMVP, RYZB, VIVS stocks.
What was Richard A. Heyman’s latest transaction?
Richard A. Heyman’s latest transaction was an Uninformative Buy of $5.60K.
What is Richard A. Heyman's role in Oric Pharmaceuticals?
Richard A. Heyman's role in Oric Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.